Applied Genetic Technologies Corp. - news published 101 - readings 2.693

BACK
Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investmen ...

Continue reading
01.12.2022
Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investmen ...

Continue reading
01.12.2022
Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investmen ...

Continue reading
01.12.2022
Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investmen ...

Continue reading
01.12.2022
Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investmen ...

Continue reading
01.12.2022
Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Post-effective Amendment to Registration Statement for Employee Benefit Plan - Form S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 1, 2022 Registration Nos. 333-267635 333-259746 333-248900 333-233955 333-198979 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. 333-267635 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. ...

Continue reading
01.12.2022
Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investmen ...

Continue reading
01.12.2022
Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Post-effective Amendment to Registration Statement for Employee Benefit Plan - Form S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 1, 2022 Registration Nos. 333-267635 333-259746 333-248900 333-233955 333-198979 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. 333-267635 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. ...

Continue reading
01.12.2022
Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Post-effective Amendment to Registration Statement for Employee Benefit Plan - Form S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 1, 2022 Registration Nos. 333-267635 333-259746 333-248900 333-233955 333-198979 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. 333-267635 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. ...

Continue reading
01.12.2022
Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Post-effective Amendment to Registration Statement for Employee Benefit Plan - Form S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 1, 2022 Registration Nos. 333-267635 333-259746 333-248900 333-233955 333-198979 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. 333-267635 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. ...

Continue reading
01.12.2022
Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investmen ...

Continue reading
01.12.2022
Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investmen ...

Continue reading
01.12.2022
Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Post-Effective Amendment to Registration Statement - Form POS AM

POS AM As filed with the Securities and Exchange Commission on December 1, 2022 Registration Nos. 333-255008 333-225286 333-204064 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to Form S-3, Registration Statement No. 333-255008 Post-Effective Amendment No. 1 to Form S-3, Registration Statement No. 333-225286 Post-Effecti ...

Continue reading
01.12.2022
Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Post-Effective Amendment to Registration Statement - Form POS AM

POS AM As filed with the Securities and Exchange Commission on December 1, 2022 Registration Nos. 333-255008 333-225286 333-204064 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to Form S-3, Registration Statement No. 333-255008 Post-Effective Amendment No. 1 to Form S-3, Registration Statement No. 333-225286 Post-Effecti ...

Continue reading
01.12.2022